High-precision systems optimized for Belgian clinical and research standards.
Belgium stands as a global powerhouse in biotechnology and pharmaceutical innovation. With clusters like Flanders.bio and the BioWin health cluster in Wallonia, the country is home to some of the world's most advanced genomic research centers and diagnostic laboratories. From the VIB (Vlaams Instituut voor Biotechnologie) to major university hospitals in Brussels, Leuven, and Ghent, the demand for high-throughput, reliable DNA analysis systems is at an all-time high.
The Belgian market requires more than just hardware; it demands Information Gain and technical synergy. Our DNA analysis systems are engineered to integrate seamlessly with European laboratory information management systems (LIMS) and comply strictly with the FAMHP (Federal Agency for Medicines and Health Products) regulations. As Belgium continues to lead in personalized medicine and vaccine development, our factory-direct supply chain ensures that local institutions have access to the same precision engineering used in the world's top-tier bio-foundries.
Current industrial trends in Belgium show a massive shift toward Automated Molecular Diagnostics. Labor shortage in specialized lab roles and the need for 24/7 testing capabilities have pushed hospitals in Antwerp and Liege to seek "plug-and-play" systems that offer high analytical sensitivity without sacrificing throughput speed. Our current roadmap aligns with this "Industry 4.0" approach to biotech, offering IoT-enabled imaging systems and energy-efficient electrophoresis tanks.
We serve the Belgian market by adhering to international procurement standards required by global pharma giants (GSK, Janssen Pharmaceutica) located in-country:
Our systems provide a comprehensive solution for:
Manufacturing Base
Industry Leadership
Global Export Reach
Expert Technicians
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
All our DNA analysis software modules are designed with Belgian and EU GDPR regulations in mind, ensuring patient data remains encrypted and sovereign.
Our equipment undergoes rigorous testing to meet the In Vitro Diagnostic Medical Devices Regulation (IVDR) 2017/746, mandatory for the Belgian market.
By utilizing Antwerp’s world-class port and Brussels Airport (Zaventem), we offer expedited delivery and duty-paid (DDP) options for our Belgian clients.
Our systems feature open-architecture software and standard API outputs (JSON/XML) that allow for direct integration with mainstream LIMS used across the Benelux region, ensuring minimal disruption during installation.
Typically, standard configurations are dispatched within 7-10 working days. With air freight to Zaventem, Belgian customers usually receive their equipment within 15-20 days from order confirmation.
Yes, we partner with specialized medical device distributors across Flanders and Wallonia who provide first-line technical support, calibration services, and on-site maintenance.
Absolutely. We offer OEM/ODM services where we can adjust sensor sensitivity, camera resolution (up to 5.2MP or higher), and software analysis algorithms to meet specific research objectives at institutions like KU Leuven or UGent.
Extended solutions for comprehensive genetic and protein analysis.
BioX Medical
